T1	Participants 99 135	patients with advanced breast cancer
T2	Participants 275 299	metastatic breast cancer
T3	Participants 477 519	anthracycline-pretreated patients with MBC
T4	Participants 1847 1886	women with anthracycline-pretreated MBC
